Acceleration of matrix metalloproteinase-1 production and activation of platelet-derived growth factor receptor β in human coronary smooth muscle cells by oxidized LDL and 4-hydroxynonenal

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1763, Issue 8, 2006, Pages 797-804

  Akiba, Satoshi ^a   Kumazawa, Satomi ^a   Yamaguchi, Hidenori ^a   Hontani, Naoya ^a   Matsumoto, Takeyoshi ^a   Ikeda, Takako ^a   Oka, Mayuko ^a   Sato, Takashi ^a  

^a KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Matrix metalloproteinase; Oxidized LDL; Platelet derived growth factor receptor; Smooth muscle cell

Indexed keywords

4 HYDROXYNONENAL; INTERSTITIAL COLLAGENASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; OXIDIZED LOW DENSITY LIPOPROTEIN; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR;

ARTICLE; ATHEROGENESIS; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; ENZYME SYNTHESIS; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; OXIDATION; PRIORITY JOURNAL; PROTEIN FUNCTION; SMOOTH MUSCLE FIBER;

ALDEHYDES; BASE SEQUENCE; CELLS, CULTURED; CORONARY VESSELS; DNA, COMPLEMENTARY; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; KINETICS; LIPOPROTEINS, LDL; MATRIX METALLOPROTEINASE 1; MUSCLE, SMOOTH, VASCULAR; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR BETA;

EID: 33746951927     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2006.06.003     Document Type: Article

References (37)

1. Steinberg D. Low density lipoprotein oxidation and its pathobiological significance. J. Biol. Chem. 272 (1997) 20963-20966
2. Chisolm III G.M., Hazen S.L., Fox P.L., and Cathcart M.K. The oxidation of lipoproteins by monocytes-macrophages. Biochemical and biological mechanisms. J. Biol. Chem. 274 (1999) 25959-25962
3. Ross R. Atherosclerosis. An inflammatory disease. N. Engl. J. Med. 340 (1999) 115-126
4. Lusis A.J. Atherosclerosis. Nature 407 (2000) 233-241
5. de Winther M.P.J., and Hofker M.H. Scavenging new insights into atherogenesis. J. Clin. Invest. 105 (2000) 1039-1041
6. Falk E., Shah P.K., and Fuster V. Coronary plaque disruption. Circulation 92 (1995) 657-671
7. Hajjar D.P., and Haberland M.E. Lipoprotein trafficking in vascular cells. Molecular Trojan horses and cellular saboteurs. J. Biol. Chem. 272 (1997) 22975-22978
8. Ruef J., Rao G.N., Li F., Bode C., Patterson C., Bhatnagar A., and Runge M.S. Induction of rat aortic smooth muscle cell growth by the lipid peroxidation product 4-hydroxy-2-nonenal. Circulation 97 (1998) 1071-1078
9. Hoff H.F., O'Neil J., Wu Z., Hoppe G., and Salomon R.L. Phospholipid hydroxyalkenals. Biological and chemical properties of specific oxidized lipids present in atherosclerotic lesions. Arterioscler. Thromb. Vasc. Biol. 23 (2003) 275-282
10. Galis Z., and Khatri J.J. Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly. Circ. Res. 90 (2002) 251-262
11. Heeneman S., Cleutjens J.P., Faber B.C., Creemers E.E., van Suylen R.J., Lutgens E., Cleutjens K.B., and Daemen M.J. The dynamic extracellular matrix: intervention strategies during heart failure and atherosclerosis. J. Pathol. 200 (2003) 516-525
12. Katsuda S., and Kaji T. Atherosclerosis and extracellular matrix. J. Atheroscler. Thromb. 10 (2003) 267-274
13. Visse R., and Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ. Res. 92 (2003) 827-839
14. Nikkari S.T., O'Brien K.D., Ferguson M., Hatsukami T., Welgus H.G., Alpers C.E., and Clowes A.W. Interstitial collagenase (MMP-1) expression in human carotid atherosclerosis. Circulation 92 (1995) 1393-1398
15. Major T.C., Liang L., Lu X., Rosebury W., and Bocan T.M.A. Extracellular matrix metalloproteinase inducer (EMMPRIN) is induced upon monocyte differentiation and is expressed in human atheroma. Arterioscler. Thromb. Vasc. Biol. 22 (2002) 1200-1207
16. Sukhova G.K., Schönbeck U., Rabkin E., Schoen F.J., Poole A.R., Billinghurst R.C., and Libby P. Evidence for increased collagenolysis by interstitial collagenases-1 and -3 in vulnerable human atheromatous plaques. Circulation 99 (1999) 2503-2509
17. Herman M.P., Sukhova G.K., Libby P., Gerdes N., Tang N., Horton D.B., Kilbride M., Breitbart R.E., Chun M., and Schönbeck U. Expression of neutrophil collagenase (matrix metalloproteinase-8) in human atheroma: a novel collagenolytic pathway suggested by transcriptional profiling. Circulation 104 (2001) 1899-1904
18. Kuzuya M., and Iguchi A. Role of matrix metalloproteinases in vascular remodeling. J. Atheroscler. Thromb. 10 (2003) 275-282
19. Watari M., Watari H., DiSanto M.E., Chacko S., Shi G.P., and Strauss III J.F. Pro-inflammatory cytokines induce expression of matrix-metabolizing enzymes in human cervical smooth muscle cells. Am. J. Pathol. 154 (1999) 1755-1762
20. Chase A.J., Bond M., Crook M.F., and Newby A.C. Role of nuclear factor-κB activation in metalloproteinase-1, -3, and -9 secretion by human macrophages in vitro and rabbit foam cells produced in vivo. Arterioscler. Thromb. Vasc. Biol. 22 (2002) 765-771
21. Lee W.H., Kim S.H., Lee Y., Lee B.B., Kwon B., Song H., Kwon B.S., and Park J.E. Tumor necrosis factor receptor superfamily 14 is involved in atherogenesis by inducing proinflammatory cytokines and matrix metalloproteinases. Arterioscler. Thromb. Vasc. Biol. 21 (2001) 2004-2010
22. Gerdes N., Sukhova G.K., Libby P., Reynolds R.S., Young J.L., and Schönbeck U. Expression of interleukin (IL)-18 and functional IL-18 receptor on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for atherogenesis. J. Exp. Med. 195 (2002) 245-257
23. Huang Y., Mironova M., and Lopes-Virella M.F. Oxidized LDL stimulates matrix metalloproteinase-1 expression in human vascular endothelial cells. Arterioscler. Thromb. Vasc. Biol. 19 (1999) 2640-2647
24. Xu X.P., Meisel S.R., Ong J.M., Kaul S., Cercek B., Rajavashisth T.B., Sharifi B., and Shah P.K. Oxidized low-density lipoprotein regulates matrix metalloproteinase-9 and its tissue inhibitor in human monocyte-derived macrophages. Circulation 99 (1999) 993-998
25. Rajavashisth T.B., Xu X.P., Jovinge S., Meisel S., Xu X.O., Chai N.N., Fishbein M.C., Kaul S., Cercek B., Sharifi B., and Shah P.K. Membrane type 1 matrix metalloproteinase expression in human atherosclerotic plaques: evidence for activation by proinflammatory mediators. Circulation 99 (1999) 3103-3109
26. Akiba S., Yoneda Y., Ohno S., Nemoto M., and Sato T. Oxidized LDL activates phospholipase A2 to supply fatty acids required for cholesterol esterification. J. Lipid Res. 44 (2003) 1676-1685
27. 2 and PDGF in mesangial cells. Am. J. Physiol. 282 (2002) F485-F491
28. Sun Y., Wenger L., Brinckerhoff C.E., Misra R.R., and Cheung H.S. Basic calcium phosphate crystals induce matrix metalloproteinase-1 through the Ras/mitogen-activated protein kinase/c-Fos/AP-1/metalloproteinase 1 pathway. Involvement of transcription factor binding sites AP-1 and PEA-3. J. Biol. Chem. 277 (2002) 1544-1552
29. Conway A.M., Rakhit S., Pyne S., and Pyne N.J. Platelet-derived-growth-factor stimulation of the p42/p44 mitogen-activated protein kinase pathway in airway smooth muscle: role of pertussis-toxin-sensitive G-proteins, c-Src tyrosine kinases and phosphoinositide 3-kinase. Biochem. J. 337 (1999) 171-177
30. Hayashi K., Takahashi M., Kimura K., Nishida W., Saga H., and Sobue K. Changes in the balance of phosphoinositide 3-kinase/protein kinase B (Akt) and the mitogen-activated protein kinases (ERK/p38MAPK) determine a phenotype of visceral and vascular smooth muscle cells. J. Cell Biol. 145 (1999) 727-740
31. Escargueil-Blanc I., Salvayre R., Vacaresse N., Jürgens G., Darblade B., Arnal J.F., Parthasarathy S., and Nègre-Salvayre A. Mildly oxidized LDL induces activation of platelet-derived growth factor β-receptor pathway. Circulation 104 (2001) 1814-1821
32. Luo H., and Reidy M.A. Activation of big mitogen-activated protein kinase-1 regulates smooth muscle cell replication. Arterioscler. Thromb. Vasc. Biol. 22 (2002) 394-399
33. Absood A., Furutani A., Kawamura T., and Graham L.M. Differential PDGF secretion by graft and aortic SMC in response to oxidized LDL. Am. J. Physiol. 283 (2002) H725-H732
34. Locher R., Brandes R.P., Vetter W., and Barton M. Native LDL induces proliferation of human vascular smooth muscle cells via redox-mediated activation of ERK 1/2 mitogen-activated protein kinases. Hypertension 39 (2002) 645-650
35. Akiba S., Chiba M., Mukaida Y., and Sato T. Involvement of reactive oxygen species and SP-1 in fibronectin production by oxidized LDL. Biochem. Biophys. Res. Commun. 310 (2003) 491-497
36. Game B.A., Maldonado A., He L., and Huang Y. Pioglitazone inhibits MMP-1 expression in vascular smooth muscle cells through a mitogen-activated protein kinase-independent mechanism. Atherosclerosis 178 (2005) 249-256
37. Suc I., Meilhac O., Lajoie-Mazenc I., Vandaele J., Jürgens G., Salvayre R., and Nègre-Salvayre A. Activation of EGF receptor by oxidized LDL. FASEB J. 12 (1998) 665-671